SAM
MRNA icon

Sectoral Asset Management’s Moderna MRNA Stock Holding History

Sectoral Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Hold
4,350
– – 0.21% 72
2026
Q1 		$248K Sell
4,350
-655
-13% -$30.6K 0.21% 73
2025
Q4 		$148K Sell
5,005
-595
-11% -$16.2K 0.12% 74
2025
Q3 		$145K Hold
5,600
– – 0.09% 80
2025
Q2 		$155K Hold
5,600
– – 0.1% 90
2025
Q1 		$159K Buy
5,600
+1,250
+29% +$44.4K 0.12% 76
2024
Q4 		$181K Sell
4,350
-9,610
-69% -$459K 0.12% 80
2024
Q3 		$933K Sell
13,960
-8,150
-37% -$748K 0.55% 51
2024
Q2 		$2.63M Buy
22,110
+7,370
+50% +$933K 1.07% 27
2024
Q1 		$1.57M Sell
14,740
-1,360
-8% -$137K 0.62% 51
2023
Q4 		$1.6M Buy
16,100
+1,100
+7% +$92.5K 0.69% 59
2023
Q3 		$1.55M Buy
15,000
+2,172
+17% +$242K 0.3% 92
2023
Q2 		$1.56M Sell
12,828
-4,890
-28% -$652K 0.26% 96
2023
Q1 		$2.72M Hold
17,718
– – 0.52% 74
2022
Q4 		$3.18M Sell
17,718
-575
-3% -$94K 0.62% 65
2022
Q3 		$2.16M Buy
18,293
+200
+1% +$30.3K 0.43% 78
2022
Q2 		$2.58M Buy
18,093
+888
+5% +$127K 0.52% 73
2022
Q1 		$2.96M Sell
17,205
-850
-5% -$143K 0.53% 69
2021
Q4 		$4.59M Buy
18,055
+1,450
+9% +$424K 0.69% 58
2021
Q3 		$6.39M Buy
16,605
+3,955
+31% +$1.46M 0.53% 79
2021
Q2 		$2.97M Sell
12,650
-3,200
-20% -$572K 0.24% 99
2021
Q1 		$2.08M Sell
15,850
-110,456
-87% -$16M 0.16% 94
2020
Q4 		$13.2M Sell
126,306
-9,650
-7% -$976K 0.93% 43
2020
Q3 		$9.62M Buy
135,956
+23,700
+21% +$1.65M 0.83% 51
2020
Q2 		$7.21M Buy
112,256
+90,256
+410% +$4.94M 0.66% 57
2020
Q1 		$659K Buy
+22,000
New +$506K 0.13% 61

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Sectoral Asset Management's MRNA Position: Q2 2026 in Review

Sectoral Asset Management held its Moderna (MRNA) position steady in Q2 2026 at 4,350 shares worth $305K. The position accounts for 0.21% of the portfolio, ranked #72.

Sectoral Asset Management first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $13.2M in Q4 2020. 781 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sectoral Asset Management held 4,350 shares of Moderna worth $305K as of Q2 2026.
  • Sectoral Asset Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.21% of Sectoral Asset Management's portfolio in Q2 2026, its #72 holding.
  • Sectoral Asset Management first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Sectoral Asset Management's Moderna position peaked at $13.2M in Q4 2020.
  • 781 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.